Benoit Jacob b11343e15c fix intermittend failure of schur_real test: there only is an iterative process if size>2

2010-12-10 02:10:03 -05:00

bench

compilation fix

2010-12-09 19:46:26 +01:00

blas

Remove parentheses for compatibility with cmake 2.6.2

2010-11-24 22:26:13 +00:00

cmake

Improves the filter for hidden files in "Eigen" and "Eigen/src".

2010-11-22 10:47:07 -05:00

debug

Improved the fixed size array display.

2010-10-20 11:56:29 +02:00

demos

bug #86 : use internal:: namespace instead of ei_ prefix

2010-10-25 10:15:22 -04:00

doc

add main ei_* functions into Eigen2Support

2010-12-03 11:22:35 +01:00

Eigen

suppress stupid warning

2010-12-10 15:53:13 +01:00

scripts

finish the change of adding .sh extensions to scripts

2010-05-30 15:58:11 -04:00

test

fix intermittend failure of schur_real test: there only is an iterative process if size>2

2010-12-10 02:10:03 -05:00

unsupported

dos2unix

2010-11-26 10:10:26 -05:00

.hgignore

fix some warnings

2010-05-22 19:17:04 +02:00

.krazy

* Add Hyperplane::transform(Matrix/Transform)

2008-08-31 13:32:29 +00:00

CMakeLists.txt

Allow unset ${CMAKE_BUILD_TYPE} which is required for some targets and corresponding to using default values.

2010-10-25 18:49:39 +02:00

COPYING.GPL

there's no reason why we should follow the FSF's stupid recommendation for the naming of these files, right? This could give the wrong impression that Eigen is only GPL-licensed.

2009-11-14 23:26:07 -05:00

COPYING.LGPL

add SSE path for Matrix4f inverse, taken from Intel except that we do a kosher

2009-12-14 22:47:14 -05:00

CTestConfig.cmake

Raise the error/warning limit.

2010-06-20 22:38:36 +02:00

eigen3.pc.in

* eigen2->eigen3

2009-11-19 12:09:04 -05:00

INSTALL

finally, the right fix: set CTEST_BUILD_TARGET.

2009-10-04 20:27:44 -04:00

signature_of_eigen3_matrix_library

improve the scripts for building unit tests:

2009-11-25 21:26:37 -05:00

Description

No description provided

MPL-2.0 119 MiB

Languages

C++ 85.6%

Fortran 8.9%

CMake 2%

C 1.6%

Cuda 1.2%

Other 0.6%